Results 91 to 100 of about 24,593 (214)

慢性肝衰竭患者终末期肝病模型预后判断的分析

open access: yesZhongguo shiyan zhenduanxue, 2008
目的探讨终末期肝病模型(MELD)在慢性肝衰竭患者预后判断的意义。方法对152例慢性肝衰竭患者的临床资料进行回顾性分析,计算入院时MELD分值及药物治疗2周后MELD分值与入院时MELD分值的差值ΔMELD,同时了解患者3个月病死率。结果9例患者在3个月内死亡,MELD分值在MELD≤9 ...
纪民, 刘威, 崔振兴, 王淑兰
doaj  

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure

open access: yesArtificial Organs, EarlyView.
Extracorporeal albumin dialysis (OPAL) effectively reduces bilirubin and improves other laboratory markers in posthepatectomy liver failure, particularly in secondary forms. It may serve as a bridging therapy to support hepatic recovery in critically ill patients, although prospective studies are needed to confirm its impact on survival.
Dorian Marckmann   +16 more
wiley   +1 more source

Macau as Method: Recombinant Urbanism in Post‐Socialist China

open access: yesAsia Pacific Viewpoint, EarlyView.
ABSTRACT In ‘Asia as Method’, Chen Kuan‐Hsing argues for the value of an indigenous inter‐Asian approach to analysing the effects of European imperialism on the countries and citizens of Asia. This article mobilises both Chen's inter‐Asian referencing strategy and the city‐state of Macau to explore Macau's role in China's engagements with global ...
Tim Simpson
wiley   +1 more source

“Yet the Problem Remains”: Why Genetic Determinism Still Haunts Biomedical Research

open access: yesBioethics, EarlyView.
ABSTRACT After the horrors of the Holocaust and its connections to eugenics were revealed to the world, many post‐war population geneticists sought to establish rhetorical distance from the Nazi's state‐led campaigns, without abandoning their belief that actively shaping the population's genetics would produce a prosperous society.
Christopher R. Donohue, Ian A. Myles
wiley   +1 more source

When Is Social Value Proportionate to Research Risks?

open access: yesBioethics, EarlyView.
ABSTRACT Ethical human subjects research must have an acceptable risk‐benefit ratio, which requires that the net risks participants face be proportionate to the research's social value. Yet existing scholarship does not explain what makes risks proportionate to social value.
Robert Steel
wiley   +1 more source

Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias

open access: yesBMC Medical Research Methodology
Background Eurotransplant liver transplant candidates are prioritized by Model for End-stage Liver Disease (MELD), a 90-day waitlist survival risk score based on the INR, creatinine and bilirubin.
H. C. de Ferrante   +4 more
doaj   +1 more source

Quantitative Metrics for Edge Bundling of Network Visualizations

open access: yesComputer Graphics Forum, EarlyView.
Abstract Edge bundling is widely used for reducing visual clutter in large 2D network and trajectory visualizations. Various edge bundling methods have been proposed, each producing qualitatively distinct outputs for the same data; however, few quantitative metrics exist for systematic evaluation. In this paper, we propose a set of quantitative metrics
M. Wallinger   +3 more
wiley   +1 more source

Ecologization Is Not a Metaphor: Museums in the Web of Life

open access: yesCurator: The Museum Journal, EarlyView.
ABSTRACT This article documents and critiques emerging accounts of museum “ecologization”. Drawing on political ecology, materialist theory, and contemporary museum practice, we challenge dominant frameworks of ecological modernization and advocate for a more critical understanding of museums in the web of life.
Colin Sterling   +2 more
wiley   +1 more source

Realizing the unexpected: How cospecialization supports the serendipity journey in SMEs' digital transformation

open access: yesEuropean Management Review, EarlyView.
Abstract Although innovation is often portrayed as arising deterministically from deliberate strategy and calculated decisions, many significant breakthroughs emerge not from planning but serendipitously. Building on this insight, this paper bridges the literatures on dynamic capabilities and serendipity to examine how SMEs realize serendipitous value ...
Marco Balzano   +2 more
wiley   +1 more source

Impact of Treatment Response to Anticoagulant Therapy on Liver‐Related Events in Patients With Cirrhosis and Portal Vein Thrombosis

open access: yesHepatology Research, EarlyView.
In patients with cirrhosis and a first portal vein thrombosis treated with intravenous anticoagulant therapy, the 3‐year cumulative rates of liver‐related events were 56.7% and 75.5% in the effective and ineffective groups, respectively. A good radiological response was associated with fewer liver‐related hospitalizations.
Atsushi Maeda   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy